Obsidian Therapeutics Stock Forecast
NASDAQ: OBXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
OBX analyst consensus
Consensus (5 analysts)
strong_buy
Avg. price target
$39.00+195.45%
- Strong buy 1
- Buy 4
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 5 Wall Street analysts covering Obsidian Therapeutics (2026-10-08), 5 rate the stock a buy or strong buy, 0 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "strong_buy". The average 12-month price target is $39.00, with a high estimate of $43.00 and a low estimate of $32.00. The average target implies upside of 195.5% from the current price of $13.20.
The spread between the highest and lowest targets is 34.4%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for OBX.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 1 | 20% |
| Buy | 4 | 80% |
| Hold | 0 | 0% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-08.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $32.00 | +142.42% |
| Average target | $39.00 | +195.45% |
| High target | $43.00 | +225.76% |